cisplatin

Open Access
Optimal Number of Cycles of First-line Platinum-based Chemotherapy for Metastatic Urothelial Carcinoma
AKINORI MINATO, DAICHI OHNO, KAZUKI MUROOKA, YUTAKA OKUMURA, TOMOHISA TAKABA, KATSUYOSHI HIGASHIJIMA, YUJIRO NAGATA, IKKO TOMISAKI, KENICHI HARADA and NAOHIRO FUJIMOTO

In Vivo July 2024, 38 (4) 1927-1934; DOI: https://doi.org/10.21873/invivo.13648
Open Access
Cisplatin Induces Kidney Cell Death via ROS-dependent MAPK Signaling Pathways by Targeting Peroxiredoxin I and II in African Green Monkey (Chlorocebus aethiops sabaeus) Kidney Cells
HUI-NA ZHANG, WAN-QIU XIAO, DONG HUN LEE, NAN LI, YAO-YUAN FENG, TING SU, HAN-YU GU, IJOO YOON, HAIYOUNG JUNG, KYUNG HO LEE, HEE JUN CHO, YING-HAO HAN, HU-NAN SUN and TAEHO KWON

In Vivo March 2024, 38 (2) 630-639; DOI: https://doi.org/10.21873/invivo.13482
Open Access
Evaluation of Prediabetes in Cisplatin-induced Nephrotoxicity in the Short Hydration Method: A Subgroup Analysis
YOSHITAKA SAITO, TATSUHIKO SAKAMOTO, MASAKI KOBAYASHI, YOH TAKEKUMA, ISSEI HIGUCHI, KEISUKE OKAMOTO, JUN SAKAKIBARA-KONISHI, YASUSHI SHIMIZU, ICHIRO KINOSHITA and MITSURU SUGAWARA

In Vivo March 2024, 38 (2) 800-806; DOI: https://doi.org/10.21873/invivo.13504
Open Access
Polyphyllin II (PPII) Enhances the Sensitivity of Multidrug-resistant A549/DDP Cells to Cisplatin by Modulating Mitochondrial Energy Metabolism
LIAN PENG, RENYI YANG, ZHIBING WANG, HUIYING JIAN, XIAONING TAN, JIAN LI, ZUOMEI HE, RUI HUANG, PUHUA ZENG and WENHUI GAO

In Vivo January 2024, 38 (1) 213-225; DOI: https://doi.org/10.21873/invivo.13428
Open Access
Toll-like Receptor Agonist CBLB502 Protects Against Cisplatin-induced Liver and Kidney Damage in Mice
PENGZHEN NIU, WENYU ZHAO, QIONG WANG, JUNZHAO DUAN, JIE ZHU, HANJIANG FU, YONGGE WU, XIAOFEI ZHENG, DAGUANG ZHANG and CHANGHUI GE

In Vivo September 2023, 37 (5) 2044-2056; DOI: https://doi.org/10.21873/invivo.13302
Open Access
Flavokawain B Inhibits Growth of Cholangiocarcinoma Cells by Suppressing the Akt Pathway
JUN HYUK SON, YOUNG HOON CHOI, SANG HYUB LEE, WOO HYUN PAIK, JI KON RYU and YONG-TAE KIM

In Vivo May 2023, 37 (3) 1077-1084; DOI: https://doi.org/10.21873/invivo.13182
Open Access
Curcumin Sensitizes 4T1 Murine Breast Cancer Cells to Cisplatin Through PAR4 Secretion
NORMA CESILIA ARELLANO-RODRÍGUEZ, OSCAR ALBERTO ALVAREZ-QUEZADA, PABLO ZAPATA BENAVIDES, GERARDO VARGAS-ALANÍS, MOISÉS FRANCO-MOLINA, DIANA ZAMORA-ÁVILA, MARIELA ARELLANO-RODRÍGUEZ, SANTIAGO SAAVEDRA-ALONSO, JUAN MANUEL IZAGUIRRE-ÁLVAREZ and CRISTINA RODRÍGUEZ-PADILLA

In Vivo November 2022, 36 (6) 2767-2773; DOI: https://doi.org/10.21873/invivo.13013
Open Access
Neutrophil-Lymphocyte Ratio Is Associated With Occurrence of Febrile Neutropenia in Patients Treated With 5-Fluorouracil and Cisplatin
SATOMI KUMAZAWA, TOMOHIRO MIZUNO, NAOYUKI MURAMATSU, MASAKAZU HATANO, TAKENAO KOSEKI, HIROSHI MATSUOKA, KOICHI SUDA, ICHIRO UYAMA and SHIGEKI YAMADA

In Vivo September 2022, 36 (5) 2379-2383; DOI: https://doi.org/10.21873/invivo.12970
Open Access
Analysis of Risk Factors for High-dose Cisplatin-induced Renal Impairment in Head and Neck Cancer Patients
HIROYOSHI KOIDE, SATOSHI NODA, YUMI OKUNUKI, SHIGEHIRO OWAKI, TAKESHI SHIMIZU, TOMOHIRO TERADA and SHIN-YA MORITA

In Vivo September 2022, 36 (5) 2465-2472; DOI: https://doi.org/10.21873/invivo.12982
Open Access
Antihypertensive Drug Combinations Modify Cisplatin-induced Acute Kidney Injury
KOJI TAKEUCHI, RINTARO SOGAWA, SATOKO TSURUHASHI, CHIKA MOTOOKA, SAKIKO KIMURA and CHISATO SHIMANOE

In Vivo May 2022, 36 (3) 1391-1396; DOI: https://doi.org/10.21873/invivo.12843

Main menu

User menu

Search

cisplatin

Pages